Dr. Thomas Prevot is a Project Scientist and the project manager and lead of the Drug Development Program with Dr. Etienne Sibille. Dr. Prevot received his PhD in Behavioral Neuropsychopharmacology from the University of Bordeaux in France in 2015, and started his postdoctoral fellowship in CAMH in 2016. He is also an alumni of the EUREKA Institute for Translational Medicine.
Areas of Research
Dr. Prevot’s research focuses on the neurobiology of stress, aging and their interactions, and on understanding how stress and aging impact quality of life and lead to psychiatric and neurodegenerative diseases. He is the program manager of a drug development program working with Dr. Etienne Sibille. As an ethologist and a behavioural pharmacologist, he has developed a unique expertise in the field of translational research, including the characterization of novel targets for therapeutic avenues and medication development for future clinical testing. Dr. Prevot is actively involved in the translational research and medicine landscape at the University of Toronto, working across disciplines and being an advocate for bench-to-bedside discovery.
Dr. Thomas Prevot’s publications are available on Google Scholar.